1. Home
  2. SSBI vs ATYR Comparison

SSBI vs ATYR Comparison

Compare SSBI & ATYR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

SSBI

Summit State Bank

N/A

Current Price

$12.41

Market Cap

81.6M

Sector

Finance

ML Signal

N/A

Logo aTyr Pharma Inc.

ATYR

aTyr Pharma Inc.

HOLD

Current Price

$0.71

Market Cap

79.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SSBI
ATYR
Founded
1982
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
81.6M
79.2M
IPO Year
2006
2015

Fundamental Metrics

Financial Performance
Metric
SSBI
ATYR
Price
$12.41
$0.71
Analyst Decision
Buy
Analyst Count
0
5
Target Price
N/A
$8.75
AVG Volume (30 Days)
6.2K
1.9M
Earning Date
01-27-2026
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$27,374,000.00
$190,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$18,728.88
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$6.95
$0.64
52 Week High
$12.60
$7.29

Technical Indicators

Market Signals
Indicator
SSBI
ATYR
Relative Strength Index (RSI) 75.77 43.87
Support Level $12.25 $0.66
Resistance Level $12.47 $0.74
Average True Range (ATR) 0.19 0.05
MACD 0.09 0.00
Stochastic Oscillator 97.62 29.11

Price Performance

Historical Comparison
SSBI
ATYR

About SSBI Summit State Bank

Summit State Bank provides various banking products and services to individuals and businesses in Sonoma County, California. It offers personal and business checking, money market, sweep, savings, and demand accounts; time certificates of deposit; and specialized deposit accounts, such as professional, small business packaged, tiered, and retirement plan accounts. The company also provides loans, including commercial loans and leases; lines of credit; commercial real estate, small business administration, residential mortgage, and construction loans; home equity lines of credit; and term and equipment loans, as well as loans to agriculture-related businesses.

About ATYR aTyr Pharma Inc.

aTyr Pharma Inc is a biotherapeutics company engaged in the discovery and development of first-in-class medicines from its proprietary tRNA synthetase platform. The company has concentrated its research and development efforts on a newly discovered area of biology, the extracellular functionality and signaling pathways of tRNA synthetases. Its primary focus is efzofitimod, a clinical-stage product candidate which targets NRP2 to resolve chronic inflammation that can cause to fibrosis. Efzofitimod has a novel mechanism of action for potentially treating lung inflammation and fibrosis.

Share on Social Networks: